3-D Matrix, Ltd. (TSE: 7777)
Health Care · Biotechnology · JP
¥407.00
-3.10% today · +51.9% 1Y
3-D Matrix, Ltd. (TSE: 7777) operates in the Biotechnology industry within the Health Care sector. The company is valued at $328.96M and employs 129 people.
Over the last twelve months the share price has gained 51.9%, trading between 264.00 and 793.00.
Tweenvest scores 3-D Matrix, Ltd. across four factors: quality 58/100, value 21/100, growth 100/100. Its strongest factor is growth.
7777 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $328.96M
- Revenue (TTM)
- $74.78M
- P/E
- 14.93
- EPS
- 27.26
- Dividend yield
- —
- Beta (5Y)
- 0.99
- 52-week high
- ¥793.00
- 52-week low
- ¥264.00
- Avg volume (3M)
- —
- Shares outstanding
- 127.98M
- Employees
- 129
- Next earnings
- —
About 3-D Matrix, Ltd.
3-D Matrix, Ltd. specializes in pioneering self-assembling peptide technology. Its flagship product, PuraMatrix, is an innovative self-assembling peptide hydrogel with diverse applications across medical fields, including regenerative medicine, cell therapy, advanced drug delivery systems, and surgical interventions. This Tokyo-based firm was established in 2004.
- ISIN
- JP3410730000
- Founded
- 2004
- Listed since
- Oct 24, 2011
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Agenus Inc.NasdaqCM: AGEN | $334.50M | $7.43 | -3.13% |
| Indaptus Therapeutics, Inc.NasdaqCM: INDP | $334.44M | $2.44 | -2.79% |
| Artiva Biotherapeutics, Inc.NasdaqGM: ARTV | $330.99M | $6.77 | -2.45% |
| GC Corp.KOSE: A005250 | $329.56M | ₩9,750.00 | +0.72% |
| TWi Biotechnology, Inc.TPEX: 6610 | $322.75M | NT$50.20 | +11.43% |
| Ocugen, Inc.NasdaqCM: OCGN | $321.21M | $0.95 | -0.87% |
| Circio Holding ASAOB: CRNA | $319.79M | Nkr11.04 | -0.90% |
| Cypherpunk Technologies Inc.NasdaqCM: CYPH | $316.83M | $2.90 | -1.36% |
Figures last refreshed Oct 11, 2026.